Crossmark

Association of recurrent venous thromboembolism and circulating microRNAs

Crossref DOI link: https://doi.org/10.1186/s13148-019-0627-z

Published Online: 2019-02-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xiao https://orcid.org/0000-0003-3285-226X
Sundquist, Kristina

Svensson, Peter J.

Rastkhani, Hamideh

Palmér, Karolina

Memon, Ashfaque A.

Sundquist, Jan

Zöller, Bengt
Funding

Funding for this research was provided by:

Swedish Heart-Lung Foundation,

ALF funding from Region Skåne

Vetenskapsrådet
License Information

Text and Data Mining valid from 2019-02-13
More Information

Article History

Received: 6 July 2018

Accepted: 4 February 2019

First Online: 13 February 2019

Ethics approval and consent to participate

: The study was performed according to the principles of the Declaration of Helsinki. All the patients have given their informed written consent before enrollment in the MATS study. The study was approved by the Ethics Committee of Lund University, (LU 237/2007).

: Written informed consents were obtained from all enrolled individuals prior to their participation.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.